Page last updated: 2024-09-03

celastrol and Respiratory Distress Syndrome

celastrol has been researched along with Respiratory Distress Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bi, Z; Chen, L; He, C; Hong, W; Lan, T; Luo, M; Que, H; Ren, W; Wan, D; Wei, X; Yang, J; Zeng, H; Zhong, A1
Wang, Y; Wei, Y1

Other Studies

2 other study(ies) available for celastrol and Respiratory Distress Syndrome

ArticleYear
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment.
    Signal transduction and targeted therapy, 2022, 12-24, Volume: 7, Issue:1

    Topics: Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Liposomes; Mice; Respiratory Distress Syndrome; SARS-CoV-2

2022
Celastrol attenuates impairments associated with lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) in rats.
    Journal of immunotoxicology, 2017, Volume: 14, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Humans; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Medicine, Chinese Traditional; NF-kappa B; Pentacyclic Triterpenes; Rats; Rats, Wistar; Respiratory Distress Syndrome; Triterpenes

2017
chemdatabank.com